AI Insight
Bacteria produce many potent antibiotics through nonribosomal peptides (NRP), compounds synthesized by large enzyme complexes called nonribosomal peptide synthetases (NRPS). These NRPS function as molecular assembly lines, with specialized modules that sequentially add amino acids together to construct peptides, similar to how parts are added at different stations in a factory production line. The process involves selection, chance mutations, and gene exchange between bacteria to diversify these antimicrobial weapons.
Why it matters
Understanding how bacteria naturally evolve and diversify their antibiotic-producing machinery could inform the development of new antibiotics to combat drug-resistant infections. This knowledge may enable scientists to engineer or predict novel antimicrobial compounds by mimicking bacterial evolutionary strategies.
Understand the Science
Many of the most potent antibiotics originate from bacteria. A large proportion belong to a class of compounds known as nonribosomal peptides (NRP). They are produced by large bacterial enzyme machineries—the nonribosomal peptide synthetases, or NRPS for short. These function like molecular assembly lines: Similar to the stations in a car factory, where new parts are added to the car at each step, several specialized modules string together amino acid by amino acid to build a peptide.
Source: Bacteria reinvent their weapons through selection, chance and gene swapping